Drug Development
Sirion Therapeutics Receives Orphan Drug Designation for Ophthalmic Drug to Treat Viral Eye Infection
Published in Lab Business Week, May 6th, 2007
Sirion Therapeutics, Inc., an ophthalmic-focused biopharmaceutical company, announced that it has received orphan drug designation from the Food and Drug Administration (FDA) for its anti-viral therapy, ganciclovir, for the treatment of acute herpetic keratitis. The product is currently marketed by Laboratoires Thea in Europe under the brand name of Virgan(R). Sirion licensed the rights to Virgan(R) for the United States from Laboratoires Thea in January 2007.
Orphan drug designation is a special status for diseases or conditions affecting fewer than 200,000 patients in the United States, granted by FDA upon request by a sponsor. Drugs that receive orphan drug...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
Source: Lab Business Week (2007-05-06)
More Articles from Lab Business Week
- Biochemistry
Studies from Haskins Laboratories yield new data on biochemistry - Cell Biology
Research from Abbott Laboratories in the area of cell biology published - Chemotherapy
Reports from Haskins Laboratories highlight recent research in chemotherapy - Drug Development
Mylan Announces Final FDA Approval for Glipizide and Metformin Hydrochloride Tablets - Flu Vaccines
Carrington Subsidiary DelSite Biotechnologies Secures Antigen for Phase I Clinical Trial of Nasal Powder Influenza Vaccine - Hepatitis C Virus Therapy
Researchers from Abbott Laboratories report on findings in hepatitis C virus therapy - More from this issue of Lab Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
